Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgery.
Discussion on Tregs that have anti-inflammatory and anti-atherogenic properties as an ideal therapeutic target to reduce fatal cardiovascular deaths following major noncardiac surgery.
PMID: 31608500 [PubMed - as supplied by publisher]
Source: Journal of Leukocyte Biology - Category: Hematology Authors: Kyaw T, Bobik A Tags: J Leukoc Biol Source Type: research
More News: Biology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Hematology